Diagnostics and drug discovery work hand in hand
Breakthrough approach to rapid cancer drug discovery covered by Seattle Business Magazine Editor in Chief Leslie Helm
SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform
SEngine Precision Medicine Announces Experienced Technology Executive Tom Neary as Chief Financial Officer
We look forward to updating you quarterly on our progress as we work together to fulfill our vision of a future when every cancer patient receives personalized, effective and less-toxic treatment.
Learn about new partnerships, additions to our growing team, progress in efforts to advance new drugs and other company news in SEngine Precision Medicine quarterly newsletter.